The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation

Viktória Reményi, Gabriella Inczédy-Farkas, Anikó Gál, B. Bereznai, Zsuzsanna Pál, V. Karcagi, Ferenc Mechler, Mária Judit Molnár

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Mutations of both the PMP22 and EGR2 genes cause Charcot-Marie-Tooth (CMT) disease type 1. Deletion of the PMP22 gene, results in hereditary neuropathy with liability to pressure palsies. More publications exist about the interaction of PMP22 duplication and other CMT-causing gene mutations. In these cases the intrafamiliar discordant phenotypes draw the attention to the possible role of modifying genes. The gene-gene interactions between the PMP22 and EGR2 genes are not well understood. Case report: We report two brothers with late onset CMT1 due to a c. 1142 G>A (Arg381 His) heterozygous substitution in the ECR2 gene. Additionally, the older brother with the less severe symptoms harbored the PMP22 gene deletion also. Conclusion: The coexistence of the two genetic alterations did not aggravate the clinical symptoms. Moreover, the PMP22 deletion appeared to have a beneficial modifying effect, thus implying potential gene-gene interaction of PMP22 and EGR2. PMP22 deletion may increase Schwann cells proliferation and compensate the dominant-negative effect of the Arg381 His substitution in the EGR2 gene.

Original languageEnglish
Pages (from-to)420-425
Number of pages6
JournalIdeggyógyászati szemle
Volume67
Issue number11-12
Publication statusPublished - Nov 30 2014

Fingerprint

Tooth
Mutation
Genes
Gene Deletion
Charcot-Marie-Tooth Disease
Schwann Cells
Publications
Cell Proliferation
Phenotype

Keywords

  • CMT
  • Coexistence
  • EGR2 gene mutation
  • Gene-gene interaction
  • PMP22 deletion

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Medicine(all)

Cite this

The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation. / Reményi, Viktória; Inczédy-Farkas, Gabriella; Gál, Anikó; Bereznai, B.; Pál, Zsuzsanna; Karcagi, V.; Mechler, Ferenc; Molnár, Mária Judit.

In: Ideggyógyászati szemle, Vol. 67, No. 11-12, 30.11.2014, p. 420-425.

Research output: Contribution to journalArticle

Reményi, V, Inczédy-Farkas, G, Gál, A, Bereznai, B, Pál, Z, Karcagi, V, Mechler, F & Molnár, MJ 2014, 'The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation', Ideggyógyászati szemle, vol. 67, no. 11-12, pp. 420-425.
Reményi, Viktória ; Inczédy-Farkas, Gabriella ; Gál, Anikó ; Bereznai, B. ; Pál, Zsuzsanna ; Karcagi, V. ; Mechler, Ferenc ; Molnár, Mária Judit. / The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation. In: Ideggyógyászati szemle. 2014 ; Vol. 67, No. 11-12. pp. 420-425.
@article{00c13705f16743d29f97e751bae3bae5,
title = "The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation",
abstract = "Background: Mutations of both the PMP22 and EGR2 genes cause Charcot-Marie-Tooth (CMT) disease type 1. Deletion of the PMP22 gene, results in hereditary neuropathy with liability to pressure palsies. More publications exist about the interaction of PMP22 duplication and other CMT-causing gene mutations. In these cases the intrafamiliar discordant phenotypes draw the attention to the possible role of modifying genes. The gene-gene interactions between the PMP22 and EGR2 genes are not well understood. Case report: We report two brothers with late onset CMT1 due to a c. 1142 G>A (Arg381 His) heterozygous substitution in the ECR2 gene. Additionally, the older brother with the less severe symptoms harbored the PMP22 gene deletion also. Conclusion: The coexistence of the two genetic alterations did not aggravate the clinical symptoms. Moreover, the PMP22 deletion appeared to have a beneficial modifying effect, thus implying potential gene-gene interaction of PMP22 and EGR2. PMP22 deletion may increase Schwann cells proliferation and compensate the dominant-negative effect of the Arg381 His substitution in the EGR2 gene.",
keywords = "CMT, Coexistence, EGR2 gene mutation, Gene-gene interaction, PMP22 deletion",
author = "Vikt{\'o}ria Rem{\'e}nyi and Gabriella Incz{\'e}dy-Farkas and Anik{\'o} G{\'a}l and B. Bereznai and Zsuzsanna P{\'a}l and V. Karcagi and Ferenc Mechler and Moln{\'a}r, {M{\'a}ria Judit}",
year = "2014",
month = "11",
day = "30",
language = "English",
volume = "67",
pages = "420--425",
journal = "Ideggyogyaszati Szemle",
issn = "0019-1442",
publisher = "Ifjusagi Lap-es Konyvkiado Vallalat",
number = "11-12",

}

TY - JOUR

T1 - The modifying effect a PMP22 deletion in a family with charcot-marie-tooth type 1 neuropathy due to an EGR2 mutation

AU - Reményi, Viktória

AU - Inczédy-Farkas, Gabriella

AU - Gál, Anikó

AU - Bereznai, B.

AU - Pál, Zsuzsanna

AU - Karcagi, V.

AU - Mechler, Ferenc

AU - Molnár, Mária Judit

PY - 2014/11/30

Y1 - 2014/11/30

N2 - Background: Mutations of both the PMP22 and EGR2 genes cause Charcot-Marie-Tooth (CMT) disease type 1. Deletion of the PMP22 gene, results in hereditary neuropathy with liability to pressure palsies. More publications exist about the interaction of PMP22 duplication and other CMT-causing gene mutations. In these cases the intrafamiliar discordant phenotypes draw the attention to the possible role of modifying genes. The gene-gene interactions between the PMP22 and EGR2 genes are not well understood. Case report: We report two brothers with late onset CMT1 due to a c. 1142 G>A (Arg381 His) heterozygous substitution in the ECR2 gene. Additionally, the older brother with the less severe symptoms harbored the PMP22 gene deletion also. Conclusion: The coexistence of the two genetic alterations did not aggravate the clinical symptoms. Moreover, the PMP22 deletion appeared to have a beneficial modifying effect, thus implying potential gene-gene interaction of PMP22 and EGR2. PMP22 deletion may increase Schwann cells proliferation and compensate the dominant-negative effect of the Arg381 His substitution in the EGR2 gene.

AB - Background: Mutations of both the PMP22 and EGR2 genes cause Charcot-Marie-Tooth (CMT) disease type 1. Deletion of the PMP22 gene, results in hereditary neuropathy with liability to pressure palsies. More publications exist about the interaction of PMP22 duplication and other CMT-causing gene mutations. In these cases the intrafamiliar discordant phenotypes draw the attention to the possible role of modifying genes. The gene-gene interactions between the PMP22 and EGR2 genes are not well understood. Case report: We report two brothers with late onset CMT1 due to a c. 1142 G>A (Arg381 His) heterozygous substitution in the ECR2 gene. Additionally, the older brother with the less severe symptoms harbored the PMP22 gene deletion also. Conclusion: The coexistence of the two genetic alterations did not aggravate the clinical symptoms. Moreover, the PMP22 deletion appeared to have a beneficial modifying effect, thus implying potential gene-gene interaction of PMP22 and EGR2. PMP22 deletion may increase Schwann cells proliferation and compensate the dominant-negative effect of the Arg381 His substitution in the EGR2 gene.

KW - CMT

KW - Coexistence

KW - EGR2 gene mutation

KW - Gene-gene interaction

KW - PMP22 deletion

UR - http://www.scopus.com/inward/record.url?scp=84921810220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921810220&partnerID=8YFLogxK

M3 - Article

VL - 67

SP - 420

EP - 425

JO - Ideggyogyaszati Szemle

JF - Ideggyogyaszati Szemle

SN - 0019-1442

IS - 11-12

ER -